Latest placebo Stories
-- Conference Call and Webcast Today at 5:00 p.m. ET -- FREMONT, Calif., May 5, 2015 /PRNewswire/ -- Ardelyx, Inc.
MISSISSAUGA, ON, April 22, 2015 /PRNewswire/ - Nuvo Research Inc.
ENGLEWOOD, Colo., April 20, 2015 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.
-- Slowing of Disease Progression in ALS Patients with High Levels of Inflammation Supports Further Clinical Research -- PALO ALTO, Calif., April 20, 2015 /PRNewswire/ -- Published
INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the treatment
MELBOURNE, Australia, April 20, 2015 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQX: BNOEF) , a biopharmaceutical company focused on the discovery and
WASHINGTON, April 14, 2015 /PRNewswire-USNewswire/ -- A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves
LEXINGTON, Massachusetts, April 9, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the 13-week Phase 2 IMAGO trial of its investigational compound
TOKYO and SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc.
The Study did not achieve its primary efficacy endpoint PETACH TIKVA, Israel, March 30, 2015 /PRNewswire/ -- Can-Fite
- A hairdresser.